PLIVA HRVATSKA D.O.O.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 4158
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8569371 Crystal forms of O-desmethylvenlafaxine fumarateMar 29, 11Oct 29, 13[A61K, A01N, C07C]
8372822 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereofJun 01, 12Feb 12, 13[A61K, C07D]
8217021 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereofAug 04, 11Jul 10, 12[A61K, C07D]
8138349 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleateJul 13, 07Mar 20, 12[A61K, C07D]
8022093 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereofApr 19, 11Sep 20, 11[A61K, C07D]
7569549 Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin AMar 17, 03Aug 04, 09[A61K, C07H]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2012/0142,743 PHARMACEUTICALLY ACCEPTABLE SALT AND POLYMORPHIC FORMS OF FLUPIRTINE MALEATEAbandonedFeb 09, 12Jun 07, 12[A61K, C07D, A61P]
7868174 Form of a benzenesulfonamide derivativeExpiredJul 21, 05Jan 11, 11[C07D]
2010/0272,794 PHARMACEUTICAL COMPOSITION OF MEMANTINEAbandonedNov 15, 07Oct 28, 10[A61K, A61P]
2010/0055,171 Pharmaceutical Formulation Comprising DonepezilAbandonedJun 29, 07Mar 04, 10[A61K]
2010/0016,638 Method for preparation of o-desmethylvenlafaxine using polythiolatesAbandonedJul 21, 09Jan 21, 10[C07C]
2009/0306,393 PROCESS FOR PREPARING OF, IMPURITIES FREE, SUBSTITUTED 2-BENZIMIDAZOLE-SULFOXIDE COMPOUNDAbandonedDec 14, 06Dec 10, 09[C07D]
2009/0298,879 Impurities of DonepezilAbandonedMay 18, 07Dec 03, 09[A61K, C07D, C07C, G01N, A61P]
7572773 Single dose fast dissolving azithromycinExpiredJul 22, 04Aug 11, 09[A61K]
2009/0149,427 PHARMACEUTICALLY ACCEPTABLE SALTS AND HYDRATES OF RISEDRONIC ACIDAbandonedSep 04, 06Jun 11, 09[A61K, C07F, A61P]
2009/0137,613 PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMSAbandonedMar 06, 07May 28, 09[A61K]
2009/0137,811 PROCESS FOR THE PREPARATION OF DONEPEZIL AND INTERMEDIATE COMPOUNDS THEREOF AS WELL AS HYDRATES OF DONEPEZILAbandonedJul 14, 06May 28, 09[C07D]
2008/0145,425 PHARMACEUTICAL COMPOSITION OF ZOLPIDEMAbandonedDec 15, 06Jun 19, 08[A61K, A61P]
2007/0298,102 Extended Release Pharmaceutical Composition of CelecoxibAbandonedNov 23, 05Dec 27, 07[A61K, A61P]
2007/0276,015 Crystal modification of torasemideAbandonedJul 03, 07Nov 29, 07[A61K, C07D, A61P]
2007/0225,325 Solid Forms of Montelukast AcidAbandonedJan 19, 05Sep 27, 07[C07D]
2007/0148,249 Method of preparation of oral solid dosage form with instant release of actingAbandonedNov 23, 04Jun 28, 07[A61K]
2007/0026,077 Method of producing dosage units of a solid drug form containing warfarin sodium salt as active componentAbandonedOct 14, 04Feb 01, 07[A61K]
2006/0205,951 New crystal modification of torasemideAbandonedFeb 21, 06Sep 14, 06[C07D]
2006/0100,439 Process for the preparation of modification I of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonam-ideAbandonedJul 07, 03May 11, 06[C07D]
2005/0118,266 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumpingAbandonedJan 07, 05Jun 02, 05[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.